BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21699387)

  • 1. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Michallet AS; Rossignol J; Cazin B; Ysebaert L
    Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
    Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
    Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia complicating chronic lymphocytic leukemia: rapid response to high-dose methylprednisolone and rituximab.
    Coleman N; Murphy PT; Thornton P; Quinn J
    Leuk Lymphoma; 2013 Oct; 54(10):2333-5. PubMed ID: 23480495
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.
    Zent CS; Shanafelt T
    Leuk Lymphoma; 2009 Jun; 50(6):863-4. PubMed ID: 19455465
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
    Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
    Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
    Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager SM; Reinalda MS; Rabe KG; Slager SL; Zent CS
    Leuk Lymphoma; 2010 Apr; 51(4):620-7. PubMed ID: 20302386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
    Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
    Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
    Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
    Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
    Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
    Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
    Herishanu Y; Goldschmidt N; Bairey O; Ruchlemer R; Fineman R; Rahimi-Levene N; Shvidel L; Tadmor T; Ariel A; Braester A; Shapiro M; Joffe E; Polliack A;
    Haematologica; 2015 May; 100(5):662-9. PubMed ID: 25661442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukemia resolved by Rituximab.
    Shvidel L; Shtalrid M; Berrebi A
    Leuk Lymphoma; 2004 Jul; 45(7):1493-4. PubMed ID: 15359657
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune cytopenias in chronic lymphocytic leukemia.
    D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
    Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
    Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V
    Leukemia; 2023 Jul; 37(7):1464-1473. PubMed ID: 37202442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
    De Back TR; Kater AP; Tonino SH
    Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.